-
December 9, 2011 Lupin receives Tentative Approval for Generic Cymbalta® Delayed-release Capsules
-
December 2, 2011 Lupin receives FDA Approval for Generic SOLODYN® Tablets
-
November 17, 2011 Lupin Acquires I’rom Pharmaceuticals through its Japanese Subsidiary
-
November 9, 2011 Robust Growth, Record Profits Net Profit Up 24%, Q2 FY 2011-12
-
October 28, 2011 Lupin receives Final FDA Approval for Generic LoSeasonique® Tablets
-
October 19, 2011 Lupin receives FDA approval for Generic KEPPRA® Oral Solution 100 mg / ml
-
October 11, 2011 Lupin launches Authorized Generic of Femcon® Fe
-
September 14, 2011 Lupin Announces Launch of Generic KEPPRA XR® Tablets
-
September 11, 2011 Lupin Announces U.S. FDA Approval of its First Oral Contraceptive
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications